Tag: Therapy & Procedures: Misc.
Early ECMO-Facilitated Resuscitation Ups Survival in OHCA
Findings seen among adults with out-of-hospital cardiac arrest and refractory ventricular fibrillation
TAVR Volumes in the U.S. Have Risen Each Year Since 2011
In 2019, TAVR exceeded surgical procedures; 30-day mortality and stroke rates decreased since 2011
Nebulized Interferon Beta-1a Promising for COVID-19
Adults hospitalized for COVID-19 receiving SNG001 versus placebo more likely to show clinical improvement
Risks of Opioids Should Be Recognized for Children After Surgery
Opioid prescribing guidelines for children developed; authors underscore importance of nonopioid analgesic options, providing education to patients and their families
New Cancer Drug Approvals Linked to Drop in Mortality
New cancer drugs approved between 2000 and 2016 associated with 1,291,769 fewer related deaths in the U.S.
Trial of Antibody Drug for COVID-19 Stopped for Lack of Effectiveness
Eli Lilly says government is continuing a separate study testing the antibody drug in mild to moderately ill patients
Convalescent Plasma Has Limited Benefit for Moderate COVID-19
Randomized phase II trial shows no drop in progression to severe disease, all-cause deaths
Pharmacotherapy, Psychotherapy Combo Best for Bipolar Disorder
Manualized treatments linked to significantly reduced recurrence rates versus control treatments
Outcomes Worse for Women With MI at 50 Years or Younger
Women less likely to undergo coronary revascularization, receive guideline-directed medical treatment
ACS: Tranexamic Acid No Better Than Placebo After Severe Injury
Antifibrinolytic agent may lower 30-day mortality when used within one hour of injury, for severe shock
